Derek A DuBay1, Paul A MacLennan2, Rhiannon D Reed2, Brittany A Shelton2, David T Redden3, Mona Fouad4, Michelle Y Martin5, Stephen H Gray2, Jared A White2, Devin E Eckhoff2, Jayme E Locke2. 1. Department of Surgery-Transplantation, University of Alabama at Birmingham, Birmingham, AL. Electronic address: ddubay@uabmc.edu. 2. Department of Surgery-Transplantation, University of Alabama at Birmingham, Birmingham, AL. 3. School of Public Health-Biostatistics, University of Alabama at Birmingham, Birmingham, AL. 4. Department of Medicine-Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL. 5. Department of Medicine-Preventive Medicine, University of Tennessee, Memphis, TN.
Abstract
BACKGROUND: The number of Medicaid beneficiaries has increased under the Affordable Care Act, improving access to solid organ transplantation in this disadvantaged patient cohort. It is unclear what impact Medicaid expansion will have on transplantation outcomes. We performed a retrospective cohort analysis to measure the frequency and variation in Medicaid transplantation and post-transplantation survival in Medicaid patients. STUDY DESIGN: Adult heart, lung, liver, and renal transplant recipients between 2002 and 2011 (n = 169,194) reported to the Scientific Registry of Transplant Recipients were identified. Transplant recipients were classified based on insurance status (private, Medicare or Medicaid). Outcomes measures included 5-year post-transplantation survival, summarized using Kaplan-Meier curves and compared with log-rank tests. Organ-specific Cox proportional hazards models were used to adjust for donor and recipient factors. RESULTS: Medicaid patients comprised 8.6% of all organ transplant recipients. Fewer transplantations were performed than expected among Medicaid beneficiaries for all organs except liver (liver: observed to expected ratio = 1.21; 95% CI, 0.68-1.90; heart: observed to expected ratio = 0.89; 95% CI, 0.44-1.49; lung: observed to expected ratio = 0.57; 95% CI, 0.22-1.06; renal: observed to expected ratio = 0.32; 95% CI, 0.08-0.72). Medicaid transplant recipients were listed with more severe organ failure and experienced shorter transplant wait times. Post-transplantation survival was lower in Medicaid patients compared with private insurance for all organs. Post-transplantation survival in Medicaid patients was similar to Medicare patients for heart, liver, and renal but lower in lung. CONCLUSIONS: Medicaid organ transplant beneficiaries had significantly lower survival compared with privately insured beneficiaries. The more severe organ failure among Medicaid beneficiaries at the time of listing, suggested a pattern of late referral, which might account for worse outcomes. Implementation of the Affordable Care Act gives the opportunity to develop the necessary infrastructure to ensure timely transplantation referrals and improve long-term outcomes in this vulnerable population.
BACKGROUND: The number of Medicaid beneficiaries has increased under the Affordable Care Act, improving access to solid organ transplantation in this disadvantaged patient cohort. It is unclear what impact Medicaid expansion will have on transplantation outcomes. We performed a retrospective cohort analysis to measure the frequency and variation in Medicaid transplantation and post-transplantation survival in Medicaid patients. STUDY DESIGN: Adult heart, lung, liver, and renal transplant recipients between 2002 and 2011 (n = 169,194) reported to the Scientific Registry of Transplant Recipients were identified. Transplant recipients were classified based on insurance status (private, Medicare or Medicaid). Outcomes measures included 5-year post-transplantation survival, summarized using Kaplan-Meier curves and compared with log-rank tests. Organ-specific Cox proportional hazards models were used to adjust for donor and recipient factors. RESULTS: Medicaid patients comprised 8.6% of all organ transplant recipients. Fewer transplantations were performed than expected among Medicaid beneficiaries for all organs except liver (liver: observed to expected ratio = 1.21; 95% CI, 0.68-1.90; heart: observed to expected ratio = 0.89; 95% CI, 0.44-1.49; lung: observed to expected ratio = 0.57; 95% CI, 0.22-1.06; renal: observed to expected ratio = 0.32; 95% CI, 0.08-0.72). Medicaid transplant recipients were listed with more severe organ failure and experienced shorter transplant wait times. Post-transplantation survival was lower in Medicaid patients compared with private insurance for all organs. Post-transplantation survival in Medicaid patients was similar to Medicare patients for heart, liver, and renal but lower in lung. CONCLUSIONS: Medicaid organ transplant beneficiaries had significantly lower survival compared with privately insured beneficiaries. The more severe organ failure among Medicaid beneficiaries at the time of listing, suggested a pattern of late referral, which might account for worse outcomes. Implementation of the Affordable Care Act gives the opportunity to develop the necessary infrastructure to ensure timely transplantation referrals and improve long-term outcomes in this vulnerable population.
Authors: Jeremiah G Allen; Eric S Weiss; George J Arnaoutakis; Stuart D Russell; William A Baumgartner; Ashish S Shah; John V Conte Journal: J Heart Lung Transplant Date: 2011-10-01 Impact factor: 10.247
Authors: L N Glueckert; D Redden; M A Thompson; A Haque; S H Gray; J Locke; D E Eckhoff; M Fouad; D A DuBay Journal: Am J Transplant Date: 2013-05-09 Impact factor: 8.086
Authors: Jeremiah G Allen; George J Arnaoutakis; Jonathan B Orens; John McDyer; John V Conte; Ashish S Shah; Christian A Merlo Journal: J Heart Lung Transplant Date: 2011-01 Impact factor: 10.247
Authors: Randi E Foraker; Kathryn M Rose; Chirayath M Suchindran; Patricia P Chang; Ann M McNeill; Wayne D Rosamond Journal: Circ Heart Fail Date: 2011-03-23 Impact factor: 8.790
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: C L Bryce; D C Angus; R M Arnold; C-C H Chang; M H Farrell; C Manzarbeitia; I R Marino; M S Roberts Journal: Am J Transplant Date: 2009-07-23 Impact factor: 8.086
Authors: Alexander S Goldfarb-Rumyantzev; James K Koford; Bradley C Baird; Madhukar Chelamcharla; Arsalan N Habib; Ben-Jr Wang; Shih-jui Lin; Fuad Shihab; Ross B Isaacs Journal: Clin J Am Soc Nephrol Date: 2006-01-11 Impact factor: 8.237
Authors: Sarah T Ward; Qixing Liang; Francis D Pagani; Min Zhang; Robert L Kormos; Keith D Aaronson; Andrew D Althouse; Brahmajee K Nallamothu; Donald S Likosky Journal: J Heart Lung Transplant Date: 2017-06-23 Impact factor: 10.247
Authors: Clifford Akateh; Dmitry Tumin; Eliza W Beal; Khalid Mumtaz; Joseph D Tobias; Don Hayes; Sylvester M Black Journal: Dig Dis Sci Date: 2018-03-24 Impact factor: 3.199
Authors: Krystal L Karunungan; Yas Sanaiha; Roland A Hernandez; Holly Wilhalme; Sarah Rudasill; Joseph Hadaya; Joseph DiNorcia; Peyman Benharash Journal: Liver Transpl Date: 2020-12-31 Impact factor: 5.799
Authors: Clifford Akateh; Rebecca Miller; Eliza W Beal; Dmitry Tumin; Joseph D Tobias; Don Hayes; Sylvester M Black Journal: Dig Dis Sci Date: 2019-07-22 Impact factor: 3.199
Authors: Sarah Streeter Hutcheson; Victoria Phillips; Rachel Patzer; Andrew Smith; J David Vega; Alanna A Morris Journal: Clin Transplant Date: 2018-07-11 Impact factor: 2.863
Authors: Julian Nikolaus Bucher; Maximilian Koenig; Markus Bo Schoenberg; Alexander Crispin; Michael Thomas; Martin Kurt Angele; Daniela Eser-Valeri; Alexander Lutz Gerbes; Jens Werner; Markus Otto Guba Journal: PLoS One Date: 2019-10-22 Impact factor: 3.240
Authors: Frederike Ambagtsheer; Bernadette Haase-Kromwijk; Frank J M F Dor; Greg Moorlock; Franco Citterio; Thierry Berney; Emma K Massey Journal: Transpl Int Date: 2020-05-20 Impact factor: 3.782
Authors: Christine Park; Mandisa-Maia Jones; Samantha Kaplan; Felicitas L Koller; Julius M Wilder; L Ebony Boulware; Lisa M McElroy Journal: Int J Equity Health Date: 2022-02-12